Overview

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This is a phase 1 and 2 study to assess the safety and efficacy of PAC-14028 cream in children with atopic dermatitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Amorepacific Corporation